 Cancer risk therapy hyperthyroidism Cancer incidence patients mean age years therapy mean dose MBq hyperthyroidism Follow-up patients average years Record linkage Swedish Cancer Register period identified cancers year treatment standardized incidence ratio SIR confidence interval SIRs cancers lung SIR kidney SIR survivors risks cancers stomach SIR kidney SIR brain SIR risk stomach cancer time activity significant risk malignant lymphoma expectation SIR Overall cancer risk administered dose time exposure absence increase leukemia support view radiation dose time carcinogenic total dose short time stomach cancer possible radiogenic excess